Loading…

P553: A PHASE 2, OPEN‐LABEL, MULTIARM, MULTICENTER STUDY TO EVALUATE MAGROLIMAB COMBINED WITH ANTILEUKEMIA THERAPIES FOR FIRST‐LINE, RELAPSED/REFRACTORY, OR MAINTENANCE TREATMENT OF ACUTE MYELOID LEUKEMIA

Saved in:
Bibliographic Details
Published in:HemaSphere 2022-06, Vol.6, p.452-453
Main Authors: Vyas, P., Daver, N. G., Chao, M. P., Xing, G., Renard, C., Ramsingh, G., Wei, A. H., Sallman, D. A.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2572-9241
2572-9241
DOI:10.1097/01.HS9.0000845100.10588.44